 NEW YORK, Aug. 16, 2021 PRNewswire -- DarioHealth Corp. Nasdaq: DRIO, a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial update. During the second quarter and subsequent period, we saw increasing demand for our integrated multi condition digital therapeutics solution, driven in part by the expansion of our metabolic offering into musculoskeletal and pain conditions through the acquisition of Upright Technologies in February 2021 and into behavioral health through the acquisition of wayForward in June 2021, stated Erez Raphael, Chief Executive Officer of Dario. 